at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th

Company profile
Ticker
PBH
Exchange
Website
CEO
Ronald M. Lombardi
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Prestige Brands Holdings, Inc.
SEC CIK
Corporate docs
Subsidiaries
of Prestige Consumer Healthcare Inc. • Blacksmith Brands, Inc. • C.B. Fleet Company, Incorporated • C.B. Fleet Investment Corporation • C.B. Fleet International LLC • C.B. Fleet International(s) Pte. Ltd • Care Acquisition Company Pty Limited • Care Pharmaceuticals Pty Limited • Cellegy Australia • Clear Eyes Pharma Limited ...
IRS number
201297589
PBH stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
3 Aug 23
8-K
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
3 Aug 23
ARS
2022 FY
Annual report to shareholders
29 Jun 23
DEF 14A
Definitive proxy
29 Jun 23
10-K
2023 FY
Annual report
5 May 23
8-K
Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023
4 May 23
10-Q
2023 Q3
Quarterly report
2 Feb 23
8-K
Prestige Consumer Healthcare Inc. Reports Third Quarter Results
2 Feb 23
10-Q
2023 Q2
Quarterly report
3 Nov 22
8-K
Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023
3 Nov 22
Transcripts
PBH
Earnings call transcript
2023 Q3
2 Feb 23
PBH
Earnings call transcript
2023 Q1
7 Aug 22
PBH
Earnings call transcript
2022 Q4
6 May 22
PBH
Earnings call transcript
2022 Q3
3 Feb 22
PBH
Earnings call transcript
2022 Q2
6 Nov 21
PBH
Earnings call transcript
2022 Q1
8 Aug 21
PBH
Earnings call transcript
2021 Q4
8 May 21
PBH
Earnings call transcript
2021 Q3
4 Feb 21
PBH
Earnings call transcript
2021 Q2
6 Nov 20
PBH
Earnings call transcript
2021 Q1
9 Aug 20
Latest ownership filings
4
Mary Beth Fritz
15 Sep 23
144
Notice of proposed sale of securities
14 Sep 23
4
Ronald M. Lombardi
9 Aug 23
144
Notice of proposed sale of securities
8 Aug 23
4
DAWN M. ZIER
3 Aug 23
4
NATALE S RICCIARDI
3 Aug 23
4
SHEILA HOPKINS
3 Aug 23
4
James DArecca
3 Aug 23
4
Celeste A. Clark
3 Aug 23
4
JOHN E BYOM
3 Aug 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 54.58 mm | 54.58 mm | 54.58 mm | 54.58 mm | 54.58 mm | 54.58 mm |
Cash burn (monthly) | 1.30 mm | (no burn) | (no burn) | 2.02 mm | (no burn) | (no burn) |
Cash used (since last report) | 3.83 mm | n/a | n/a | 5.93 mm | n/a | n/a |
Cash remaining | 50.75 mm | n/a | n/a | 48.65 mm | n/a | n/a |
Runway (months of cash) | 39.0 | n/a | n/a | 24.1 | n/a | n/a |
Institutional ownership, Q2 2023
98.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 270 |
Opened positions | 27 |
Closed positions | 31 |
Increased positions | 82 |
Reduced positions | 126 |
13F shares | Current |
---|---|
Total value | 2.87 tn |
Total shares | 48.56 mm |
Total puts | 1.30 k |
Total calls | 6.10 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 9.02 mm | $535.93 bn |
Vanguard | 5.73 mm | $340.55 bn |
Dimensional Fund Advisors | 3.65 mm | $217.04 bn |
MCQEF Macquarie | 3.07 mm | $182.37 bn |
STT State Street | 1.87 mm | $111.38 bn |
WHG Westwood | 1.27 mm | $75.45 bn |
IVZ Invesco | 1.25 mm | $74.37 bn |
Massachusetts Financial Services | 1.09 mm | $64.95 bn |
Geode Capital Management | 1.06 mm | $62.85 bn |
Ariel Investments | 925.74 k | $55.02 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Sep 23 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 58.92 | 2,540 | 149.66 k | 15,934 |
14 Sep 23 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Option exercise | Acquire M | No | No | 30.56 | 2,540 | 77.62 k | 18,474 |
14 Sep 23 | Fritz Mary Beth | Employee Stock Options Common Stock | Option exercise | Dispose M | No | No | 30.56 | 2,540 | 77.62 k | 5,082 |
8 Aug 23 | Lombardi Ronald M. | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 67.95 | 1,891 | 128.49 k | 270,557 |
8 Aug 23 | Lombardi Ronald M. | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 66.99 | 5,052 | 338.43 k | 272,448 |
8 Aug 23 | Lombardi Ronald M. | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 65.99 | 3,608 | 238.09 k | 277,500 |
8 Aug 23 | Lombardi Ronald M. | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 64.97 | 22,249 | 1.45 mm | 281,108 |
8 Aug 23 | Lombardi Ronald M. | Common Stock, par value $0.01 per share | Option exercise | Acquire M | No | No | 33.5 | 32,800 | 1.10 mm | 303,357 |
8 Aug 23 | Lombardi Ronald M. | Employee Stock Options Common Stock | Option exercise | Dispose M | No | No | 33.5 | 32,800 | 1.10 mm | 0 |
1 Aug 23 | John E Byom | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 2,295 | 0.00 | 50,298 |
Press releases
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
5 Sep 23
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
3 Aug 23
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
11 Jul 23
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
6 Jul 23